Todd Watanabe, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 98,945 shares at $30.36 ($3.0M) on 2025-11-24, disclosed to the SEC on 2025-11-24.
Scheduled sale ($3.0M) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.00 | 1,055 | $32K | 1.1% |
| 2 | $30.36 | 48,945 | $1.5M | 49.5% |
| 3 | $30.36 | 48,945 | $1.5M | 49.5% |
| Total | $30.36 avg | 98,945 | $3.0M | 100% |
| Filing → |
| ARQT | SELL | 2026-03-03 | $1.9M | — | Filing → |
| ARQT | SELL | 2026-02-04 | $506K | — | Filing → |
| ARQT | SELL | 2025-11-05 | $569K | — | Filing → |